Oncology
Phase 3 trials, immunotherapy, antibody-drug conjugates, targeted therapies, solid and hematologic tumors, screening and regulatory approvals.
Published issues
- Monthly oncology bulletin — September 28, 2026
Period covered: August 29 to September 28, 2026. The month was dominated by the World Conference on Lung Cancer (WCLC 2026, Seoul, September 12–15), the International Myeloma Society meeting (IMS 2026, Glasgow,…